oncology innovation

Market Access

New policies are shaping the market access landscape, such as the introduction of the EU HTA for oncology medicines.

News

Sobi chief executive Guido Oelkers is preparing his exit, but is still cutting deals, licensing a lymphoma drug from Innate for up to $580m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.